Sequenom Shares Pushed Upward in November as Decode Collapsed | GenomeWeb

NEW YORK (GenomeWeb News) – Shares of Sequenom climbed 49 percent during the month of November as the firm tries to rebound from a clinical study scandal that led to the dismissal of senior executives at the firm two months ago.

Sequenom led the 34 stocks that comprise the GenomeWeb Daily News Index, while Decode Genetics' shares dropped 88 percent as the firm filed for Chapter 11 bankruptcy protection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.